All posts tagged "CYDY"
-
2271BiotechMonkeypox Stocks Heating Up the Charts: TOMDF APDN CODX
Investors are facing the sober reality of a twin pandemic, COVID-19, and monkeypox. It’s now clear that the government missed the opportunity...
-
4051BiotechGlaxo’s New Focus After Haleon Spinoff Shines a Light on CytoDyn (OTCMKTS: CYDY) as a Takeover Target
GSK (NYSE: GSK) has a new mission and that mission is to go after major medical conditions that have no treatment. The...
-
3921Momentum & Growth4 OTC Stocks to Watch: CBDD CYBL CYDY SFOR
There’s no question about it. It’s ugly out there. Large caps, crypto, bonds, tech. You name it and they’re all down. We’ve...
-
7003BiotechFeuerstein’s Flab on Northwest Bio (NWBO) Dives Stock on Meritless Claims After Nailing Primary Endpoint
Northwest Biotherapeutics (OTCMKTS: NWBO) is now a risk-off biotech trading at a significant discount; in a “sell the news” market, there are...
-
4121BiotechVeru’s (NASDAQ: VERU) Repurposed COVID-19 Drug Facing Uphill Battle for EUA
At first glance Veru, Inc.’s (NASDAQ: VERU) COVID-19 therapy phase 3 top line results were notable but their battle for an emergency...
-
364BiotechCytoDyn (CYDY) Board Starts Anew with Dramatic Cleaning of the Top Leadership
CytoDyn (OTCMKTS: CYDY) investors waking up to the news of the departure of long term CEO and director Nader Pourhassan are probably...
-
4281BiotechCytoDyn (OTCMKTS: CYDY): A Biotech Under Seige or Preparing for a Counter Attack?
It’s abundantly clear that there is a large short interest in CytoDyn Inc. (OTCMKTS: CYDY). The bear biotech analyst Adam Feuerstein recently...
-
469BiotechWhy Todos Medical (OTCMKTS: TOMDF) is Running Ahead of the Pack
Todos Medical (OTCMKTS: TOMDF) was a value play before it started running recently based on sound fundamental analysis, and now investors are...
-
3661BiotechPicking a Bottom in CytoDyn – Right Now
CytoDyn Inc (OTCMKT: CYDY) has been under considerable selling pressure since April and nothing seems to be able to stop it. In...
-
852BiotechAtea Failure Leaves Todos Medical (TOMDF) Last Man Standing in Oral Antivirals
The big news circulating this week was of Atea Pharmaceuticals’ (NASDAQ: AVIR) COVID-19 antiviral clinical trial failure, which instantly plummeted the stock...